Medication Administration and Controlled Substance Documentation Errors
Summary
Safe medication administration was not ensured for a resident with a g-tube, GERD, and moderately impaired cognition when pantoprazole granules were administered in a manner that did not match the manufacturer’s instructions or the physician’s order. The order summary directed Protonix oral packets 40 mg to be given via g-tube twice daily and stated to mix the granules with apple sauce, while the manufacturer’s labeling for g-tube administration instructed that the packet contents be placed in a catheter-tip syringe and mixed with apple juice. During observation, an LVN prepared pantoprazole with apple sauce, then added water, and administered it via g-tube after other medications. The LVN stated she had been giving the medication with apple sauce and needed to look up the package insert or ask a supervisor. The DON reviewed the labeling and stated the instructions called for apple juice, acknowledged that the medication had been given with apple sauce and water, and stated there was a risk of g-tube clogging and that some granules might not be delivered. Accurate accountability of controlled medications was not maintained for a resident with generalized muscle weakness and no capacity to understand and make decisions when hydrocodone-acetaminophen was administered but not documented on the controlled drug record/count sheet. The resident had an order for hydrocodone-acetaminophen 10-325 mg via g-tube twice daily for pain management. During inspection of Station 4 Medication Cart 1, the bubble pack, the facility’s controlled drug record, and the eMAR were reviewed together. The bubble pack contained 21 tablets, the controlled drug record showed 22 tablets remaining with the last dose documented the prior day, and the eMAR showed a dose documented as given that morning. The LVN stated she forgot to document the medication in the book after administering it and acknowledged that controlled medications should be documented in the count sheet to maintain a record of administration and prevent misuse. Accurate accountability was also not maintained for another resident with epilepsy and status epilepticus when lacosamide was administered but not reflected correctly on the controlled drug record. The resident had an order for lacosamide 50 mg, two tablets every 12 hours for seizure control, and the bubble pack label indicated lacosamide 100 mg, one tablet every 12 hours. During the same inspection of Station 4 Medication Cart 1, the bubble pack contained 51 tablets, the controlled drug record showed 52 tablets remaining with the last dose documented the prior evening, and the eMAR showed two tablets documented as administered that morning. The LVN stated she was supposed to sign the book after removing the medication from the bubble pack and then document in the eMAR after administration. The facility policy required controlled substances to be entered immediately upon removal from controlled storage, including the date, time, amount removed, amount remaining, and nurse signature, and required medications to be administered in accordance with state and federal guidelines and the right time and route.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.